{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:24:00Z","timestamp":1694636640600},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T00:00:00Z","timestamp":1246233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T00:00:00Z","timestamp":1246233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/bmt.2009.136","type":"journal-article","created":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T10:43:47Z","timestamp":1246272227000},"page":"395-396","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dasatinib may not suppress the GVL effect of donor lymphocyte infusions for CML"],"prefix":"10.1038","volume":"45","author":[{"given":"P","family":"Garland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Dazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Marin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,29]]},"reference":[{"key":"BFbmt2009136_CR1","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/sj.leu.2404641","volume":"21","author":"MP Simula","year":"2007","unstructured":"Simula MP, Marktel S, Fozza C, Kaeda J, Szydlo RM, Nadal E et al. Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy. Leukemia 2007; 21: 943\u2013948.","journal-title":"Leukemia"},{"key":"BFbmt2009136_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1182\/blood.V95.1.67","volume":"95","author":"F Dazzi","year":"2000","unstructured":"Dazzi F, Szydlo RM, Craddock C, Cross NC, Kaeda J, Chase A et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia. Blood 2000; 95: 67\u201371.","journal-title":"Blood"},{"key":"BFbmt2009136_CR3","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/sj.bmt.1705167","volume":"36","author":"BN Savani","year":"2005","unstructured":"Savani BN, Montero A, Kurlander R, Childs R, Hensel N, Barrett AJ . Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation. Bone Marrow Transplant 2005; 36: 1009\u20131015.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2009136_CR4","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/sj.leu.2403401","volume":"18","author":"K Cwynarski","year":"2004","unstructured":"Cwynarski K, Laylor R, Macchiarulo E, Goldman J, Lombardi G, Melo JV et al. Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro. Leukemia 2004; 18: 1332\u20131339.","journal-title":"Leukemia"},{"key":"BFbmt2009136_CR5","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1182\/blood-2007-04-084814","volume":"111","author":"AE Schade","year":"2008","unstructured":"Schade AE, Schieven GL, Townsend R, Jankowska AM, Susulic V, Zhang R et al. Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation. Blood 2008; 111: 1366\u20131377.","journal-title":"Blood"},{"key":"BFbmt2009136_CR6","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1158\/1078-0432.CCR-07-4393","volume":"14","author":"R Weichsel","year":"2008","unstructured":"Weichsel R, Dix C, Wooldridge L, Clement M, Fenton-May A, Sewell AK et al. Profound inhibition of antigen-specific T-cell effector functions by dasatinib. Clin Cancer Res 2008; 14: 2484\u20132491.","journal-title":"Clin Cancer Res"},{"key":"BFbmt2009136_CR7","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1182\/blood-2008-02-138701","volume":"111","author":"SJ Blake","year":"2008","unstructured":"Blake SJ, Bruce LA, Fraser CK, Hayball JD, Hughes TP . Dasatinib suppresses in vitro natural killer cell cytotoxicity. Blood 2008; 111: 4415\u20134416.","journal-title":"Blood"},{"key":"BFbmt2009136_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2141.2008.07433.x","volume":"144","author":"F Fei","year":"2009","unstructured":"Fei F, Yu Y, Schmitt A, Rojewski MT, Chen B, Gotz M et al. Dasatinib inhibits the proliferation and function of CD4CD25 regulatory T cells. Br J Haematol 2009; 144: 195\u2013205.","journal-title":"Br J Haematol"},{"key":"BFbmt2009136_CR9","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1182\/blood-2006-09-046888","volume":"109","author":"J Cortes","year":"2007","unstructured":"Cortes J, Rousselot P, Kim DW, Ritchie E, Hamerschlak N, Coutre S et al. Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis. Blood 2007; 109: 3207\u20133213.","journal-title":"Blood"},{"key":"BFbmt2009136_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/sj.leu.2404522","volume":"21","author":"E Nadal","year":"2007","unstructured":"Nadal E, Garin M, Kaeda J, Apperley J, Lechler R, Dazzi F . Increased frequencies of CD4(+)CD25(high) T(regs) correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia 2007; 21: 472\u2013479.","journal-title":"Leukemia"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2009136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009136","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2009136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:14:35Z","timestamp":1648037675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2009136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,29]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["BFbmt2009136"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2009.136","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,29]]},"assertion":[{"value":"29 June 2009","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}